Investor
Frequently
Asked Questions
Celularity Inc (“CELU” or “CELUW”)
170 Park Ave, Florham Park, NJ 07932
Celularity was founded in 2017
Celularity’s common stock is traded on the Nasdaq Global Select Market under the symbol XXXX
Celularity does not offer a direct purchase plan for investors. You may purchase Celularity common stock through a licensed securities broker.
You can contact our Investor Relations department at investor@celularity.com
Celularity does not anticipate paying cash dividends on its common stock for the foreseeable future.
Celularity’s independent auditors are Deloitte LLP
Celularity’s outside legal counsel is Cooley LLP.
Our fiscal year end is December 31st.
Our SEC filings, when available, are listed on the SEC’s web site, www.sec.gov. You may also find our filings in our Investor Relations Center on this website.
Please email ir@celularity.com for assistance with Investor Relations questions.